253 related articles for article (PubMed ID: 24667799)
1. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
[TBL] [Abstract][Full Text] [Related]
2. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
[TBL] [Abstract][Full Text] [Related]
3. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.
Terao M; Murota H; Kimura A; Kato A; Ishikawa A; Igawa K; Miyoshi E; Katayama I
PLoS One; 2011; 6(9):e25039. PubMed ID: 21949844
[TBL] [Abstract][Full Text] [Related]
4. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
Lee SE; Lee EY; Kang SJ; Lee SH
Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
[TBL] [Abstract][Full Text] [Related]
5. Novel 11β-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV.
Boudon SM; Vuorinen A; Geotti-Bianchini P; Wandeler E; Kratschmar DV; Heidl M; Campiche R; Jackson E; Odermatt A
PLoS One; 2017; 12(2):e0171079. PubMed ID: 28152550
[TBL] [Abstract][Full Text] [Related]
6. Role of corticosteroids in skin physiology and therapeutic potential of an 11β-HSD1 inhibitor: A review.
Hall L; Hart R
Int J Dermatol; 2024 Apr; 63(4):443-454. PubMed ID: 38146184
[TBL] [Abstract][Full Text] [Related]
7. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
Itoi S; Terao M; Murota H; Katayama I
Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708
[TBL] [Abstract][Full Text] [Related]
8. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
[TBL] [Abstract][Full Text] [Related]
9. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
10. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
[TBL] [Abstract][Full Text] [Related]
11. Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes: The Role in Hapten-Induced Dermatitis.
Terao M; Itoi S; Matsumura S; Yang L; Murota H; Katayama I
Am J Pathol; 2016 Jun; 186(6):1499-510. PubMed ID: 27070821
[TBL] [Abstract][Full Text] [Related]
12. Local cortisol/corticosterone activation in skin physiology and pathology.
Terao M; Katayama I
J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
Terao M; Itoi S; Murota H; Katayama I
Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
[TBL] [Abstract][Full Text] [Related]
14. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
Sun K; Myatt L
Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005
[TBL] [Abstract][Full Text] [Related]
16. Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.
Lee NR; Kim BJ; Lee CH; Lee YB; Lee S; Hwang HJ; Kim E; Kim SH; Lee MG; Lee SE; Lavery GG; Choi EH
Sci Rep; 2020 Nov; 10(1):20237. PubMed ID: 33214595
[TBL] [Abstract][Full Text] [Related]
17. 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation.
Hardy RS; Doig CL; Hussain Z; O'Leary M; Morgan SA; Pearson MJ; Naylor A; Jones SW; Filer A; Stewart PM; Buckley CD; Lavery GG; Cooper MS; Raza K
J Pathol; 2016 Dec; 240(4):472-483. PubMed ID: 27578244
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
[TBL] [Abstract][Full Text] [Related]
19. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
20. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
